APA

Obiero C. W., Ndiaye A. G. W., Sciré A. S., Kaunyangi B. M., Marchetti E., Gone A. M., Schütte L. D., Riccucci D., Auerbach J., Saul A., Martin L. B., Bejon P., Njuguna P. & Podda A. (2017). A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against. : Frontiers in immunology.

Chicago

Obiero Christina W, Ndiaye Augustin G W, Sciré Antonella Silvia, Kaunyangi Bonface M, Marchetti Elisa, Gone Ann M, Schütte Lena Dorothee, Riccucci Daniele, Auerbach Joachim, Saul Allan, Martin Laura B, Bejon Philip, Njuguna Patricia and Podda Audino. 2017. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against. : Frontiers in immunology.

Harvard

Obiero C. W., Ndiaye A. G. W., Sciré A. S., Kaunyangi B. M., Marchetti E., Gone A. M., Schütte L. D., Riccucci D., Auerbach J., Saul A., Martin L. B., Bejon P., Njuguna P. and Podda A. (2017). A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against. : Frontiers in immunology.

MLA

Obiero Christina W, Ndiaye Augustin G W, Sciré Antonella Silvia, Kaunyangi Bonface M, Marchetti Elisa, Gone Ann M, Schütte Lena Dorothee, Riccucci Daniele, Auerbach Joachim, Saul Allan, Martin Laura B, Bejon Philip, Njuguna Patricia and Podda Audino. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against. : Frontiers in immunology. 2017.